{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0069-0315",
      "generic_name": "bevacizumab-bvzr",
      "labeler_name": "Pfizer Laboratories Div Pfizer Inc",
      "brand_name": "Zirabev",
      "active_ingredients": [
        {
          "name": "BEVACIZUMAB",
          "strength": "100 mg/4mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0069-0315-01",
          "description": "1 VIAL, SINGLE-USE in 1 CARTON (0069-0315-01)  / 4 mL in 1 VIAL, SINGLE-USE",
          "marketing_start_date": "20200113",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Pfizer Laboratories Div Pfizer Inc"
        ],
        "rxcui": [
          "2268039",
          "2268044",
          "2268047",
          "2268048"
        ],
        "spl_set_id": [
          "aa27acbd-d117-4350-aeee-17bc2e2c0ca4"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300690342016"
        ],
        "nui": [
          "N0000193543",
          "N0000178291",
          "N0000193542"
        ],
        "pharm_class_epc": [
          "Vascular Endothelial Growth Factor Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]",
          "Vascular Endothelial Growth Factor Inhibitors [MoA]"
        ],
        "unii": [
          "2S9ZZM9Q9V"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "8f385b9e-2699-46a0-8c5f-ec1d86cd609d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20200113",
      "product_id": "0069-0315_8f385b9e-2699-46a0-8c5f-ec1d86cd609d",
      "application_number": "BLA761099",
      "brand_name_base": "Zirabev",
      "pharm_class": [
        "Vascular Endothelial Growth Factor Inhibitor [EPC]",
        "Vascular Endothelial Growth Factor Inhibitors [MoA]",
        "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"
      ]
    }
  ]
}